What happened: Allstate alleges a diagnostic imaging company billed over $1.3 million for unnecessary tests on no-fault claimants through 59 clinic locations, all run by unlicensed staff.
Who's involved: Allstate Insurance companies and Titan Diagnostic Imaging Services, Inc.
What's at stake: $179,689.87 already paid, plus $1,124,278.86 in outstanding bills Allstate says it does not owe.
Why it matters: No-fault insurers face systemic diagnostic testing fraud that can exhaust claimants' benefits and inflate costs across portfolios.
Where it stands: Complaint filed October 7, 2026.
Every patient got the same test results. The same referral language. The same word-for-word medical records - right down to the recommendation that each one undergo an ultrasound "of the vertebrae."
That is the picture Allstate paints in a federal racketeering complaint filed October 7, targeting Titan Diagnostic Imaging Services, Inc. and its sole owner. According to the filing, the company submitted more than $1.3 million in billing to Allstate for diagnostic tests on auto accident claimants that were, in the complaint's words, "medically unnecessary, illusory, unlawfully rendered."
Allstate says it paid $179,689.87 before catching on. It now wants that money back - and a court order saying it owes nothing on the approximately $1,124,278.86 in outstanding bills that Titan continues to press.
The complaint, filed in the US District Court for the Eastern District of New York, brings five claims: two federal racketeering counts under RICO - the law designed to dismantle organized fraudulent enterprises - along with common law fraud, a claim that the defendants kept money they should not have kept, and a request for a court declaration that Allstate does not have to pay any of Titan's pending or future bills.
Titan is not a medical professional corporation, the complaint says. It was never registered with the New York State Education Department, which is a prerequisite for entities billing for professional medical services in the state. Its sole owner is not a licensed healthcare provider.
Despite that, the filing alleges Titan billed Allstate for three types of diagnostic tests: musculoskeletal ultrasounds, videonystagmography - a test that tracks eye movements to assess inner-ear function - and transcranial Doppler scans, which measure blood flow in the brain. The complaint says these services were billed across more than 9,000 claims.
The filing's most striking allegation is the uniformity. Allstate attaches examples showing that Titan's "Letters of Medical Necessity" used identical language for every patient. Each one stated the claimant "has been referred for musculoskeletal diagnostic sonogram to evaluate his/her acute/subacute/chronic pain and segmental dysfunction of the joints and muscles of the back." Each recommendation used the same wording. Word for word.
The complaint says the vestibular test interpretations followed the same pattern - identical summaries, identical impressions, identical recommendations across virtually every patient. And virtually all the results came back negative. The transcranial Doppler conclusions were also identical and normal in every case, the filing alleges, a result Allstate calls medically implausible given the patients' varying injuries and circumstances.
Titan did not operate from a single fixed location, according to the complaint. Instead, it allegedly ran its testing through 59 clinics scattered across the New York City metropolitan area - from the Bronx to Brooklyn to Buffalo. These clinics, the filing says, were what the complaint calls "medical mills established for the sole purpose of submitting inflated, fraudulent billing."
In some cases, the complaint alleges, as many as 23 separate entities billed Allstate for treatment on the same patient at the same clinic, all stemming from a single accident.
Allstate also alleges that Titan routinely performed ultrasounds on patients who had already received MRIs of the same body parts - sometimes on the same day. In legitimate practice, the complaint says, an ultrasound performed shortly after an MRI on the same area "virtually never provides any additional information."
The testing itself allegedly happened fast. The complaint lists representative examples of patients receiving ultrasounds the same day as their accident, three days after, or within the first week - well before the 30-day period of conservative treatment that the filing says legitimate providers would typically allow.
This is not the first time the owner has faced these kinds of allegations. The complaint details a prior federal criminal case in which he pleaded guilty in February 2019 to conspiracy to commit healthcare fraud, admitting his role in a scheme to defraud Medicare through a previous imaging company. He was sentenced to six months in prison and ordered to pay more than $195,000 in restitution.
The complaint also references a separate civil action by GEICO alleging what Allstate's filing describes as "a fundamentally similar, if not identical, healthcare fraud scheme" involving the same parties. According to the complaint, that suit accused the defendants of using "sham diagnostic testing, illegal referrals, and non-medical billing practices to extract millions of dollars from GEICO and other insurers."
Allstate is chasing actual damages of at least $179,689.87, plus triple damages under RICO, attorneys' fees, and a court order blocking further collection on the disputed billing. It also wants a declaration that it owes nothing on the $1,124,278.86 in outstanding claims - or on any future bills from Titan.
The case lands squarely in the space no-fault SIU teams navigate daily: high-volume diagnostic billing operations that exploit the speed requirements of no-fault reimbursement. The red flags the complaint catalogs - copy-paste medical records, absent referrals, same-day testing after accidents, identical results across patients - read like a textbook checklist for claims professionals watching for this pattern.
The allegations in this complaint have not been tested, and no court has ruled on the merits of Allstate's claims.
